On 8 September 2026, Bio Protocol's BIO token traded at about $0.0273, with a market capitalisation of about $58.5 million and roughly $8.8 million in 24-hour trading volume (CoinGecko daily snapshot). That price was about 97% below the all-time high of $0.889 set on 3 January 2025. The latest figures move the story on. On 25 October 2026 CoinGecko listed BIO at $0.02216, a market cap of $47.5 million and rank #465. That is roughly 19% below the 8 September level. All market figures here come from one data provider, CoinGecko, and DeFiLlama confirms only the all-time high.
Latest figures: 25 October 2026
CoinGecko's BIO page, read on 25 October 2026, showed:
| Metric | Value |
|---|---|
| Price | $0.02216 |
| 24-hour change | -4.5% |
| 7-day change | -6.4% |
| Market cap | $47.52 million |
| Market cap rank | #465 |
| 24-hour volume | $7.08 million |
| Circulating supply | 2.145 billion BIO |
| Total supply | 3.32 billion BIO |
At $0.02216, BIO sits about 97.5% below its $0.889 high of 3 January 2025. DeFiLlama, a second tracker, also gives that peak and date. It lists the all-time low as $0.016 on 29 March 2026.
The 8 September 2026 snapshot
CoinGecko's historical record for 8 September 2026 (the daily 00:00 UTC snapshot) gives:
- Price: $0.02726
- Market cap: $58.47 million
- 24-hour volume: $8.84 million
The original version of this page used a later snapshot from 13:50 UTC that day: $0.02698 and a $57.9 million market cap. Those figures sit close to CoinGecko's daily values. The 24-hour, 7-day and 30-day percentage changes in the original could not be checked against a primary record, so they have been removed.
How much veBIO does a BIO lock give?
Enter how much BIO you would lock and how many weeks are left on the lock to see the veBIO balance the documented formula gives.
| BIO locked | Weeks remaining in the lock (1 week to 2 years) | veBIO balance at this point in the lock |
|---|---|---|
| 1,000 BIO | 104 weeks | 1,000 veBIO |
| 1,000 BIO | 52 weeks | 500 veBIO |
| 1,000 BIO | 1 weeks | 9.62 veBIO |
| 5,000 BIO | 26 weeks | 1,250 veBIO |
- The BIO amount and weeks remaining are your own inputs, not figures from any source.
- The formula is the rate stated in Bio Protocol's documentation: a 2-year (104-week) lock gives 1 veBIO per BIO at the start and a 1-year lock gives 0.5.
- Staked BIO cannot be withdrawn before the lock ends, and staking is currently available only on Base.
This is arithmetic on the documented veBIO rate only: it does not estimate BioXP rewards, token price, governance weight in practice, or whether the formula changes after a future governance proposal; it is not investment advice.
What BIO is used for
Bio Protocol describes itself as "a new financial layer for funding and developing early-stage biotech." It lets researchers raise money for projects through community-owned research networks. Its documentation lists four uses for the BIO token:
- Staking for governance rights (veBIO) and rewards (BioXP).
- Taking part in new project launches.
- Providing liquidity across the ecosystem.
- Paying for specialised services such as BioAgents, the protocol's AI research agents.
Staking and veBIO
- BIO is locked for a period the holder chooses, from 1 week to 2 years. Staking is currently available only on Base.
- The lock gives veBIO at the rate of weeks remaining in the lock ÷ 104. A 2-year lock gives 1 veBIO per BIO at the start and a 1-year lock gives 0.5. The balance falls steadily as the lock nears its end, unless auto-renewal is switched on.
- Staked BIO cannot be withdrawn before the lock ends.
- Only BIO can be staked for veBIO. vBIO cannot be converted into it.
- The documentation says BIO and vBIO "remain the governance tokens of the protocol until veBIO gains sufficient adoption and a formal governance proposal is passed."
BioXP and Ignition Sales
New projects raise funds through Ignition Sales, and BioXP decides who gets priority in them.
- Anyone with USDC can join a sale, and there is no BioXP requirement to take part.
- BioXP matters only when a sale is oversubscribed. Contributors who pledge more BioXP get a larger share. Contributors who bring only USDC are counted as pledging 1 BioXP.
- If a sale ends below its target, all USDC is refunded.
- There are three ways to earn BioXP:
- staking BIO, which credits it daily; - staking ecosystem tokens, which must be claimed manually each day; - "Instant Mint," which costs $0.01 per XP, paid in BIO.
- The documentation also describes weekly BioXP rewards for creators who post about decentralised science.
- BioXP expires 14 days after it is issued.
Supply and allocation
The documentation gives a launch supply of 3,320,000,000 BIO and says supply is uncapped: new BIO can be minted through a new token contract. Price trackers show 3.32 billion as the maximum supply, so that figure reflects the current contract rather than a hard limit. The documented allocation is:
| Bucket | Share |
|---|---|
| Community (auction 20%, airdrop 6%, ecosystem incentives 25%, Molecule ecosystem fund 5%) | 56% |
| Core contributors | 21.2% |
| Investors (early backers) | 13.6% |
| Molecule | 5% |
| Advisors | 4.2% |
The documentation notes that future governance proposals can change this allocation. About 2.145 billion BIO, or roughly 65% of the 3.32 billion, was circulating on 25 October 2026.
Official contract addresses
From Bio Protocol's token documentation:
- Ethereum, BIO:
0xcb1592591996765Ec0eFc1f92599A19767ee5ffA - Ethereum, vBIO:
0x0d2ADB4Af57cdac02d553e7601456739857D2eF4 - Ethereum, veBIO:
0xF91a12742Aa609d41513a137d3c36b749F56f40C - Base, BIO:
0x226A2FA2556C48245E57cd1cbA4C6c9e67077DD2 - Base, veBIO:
0xE1B48C0279Cd95D984f1290293116c45D049A3bD - Solana, BIO:
bioJ9JTqW62MLz7UKHU69gtKhPpGi1BQhccj2kmSvUJ - BNB Chain, BIO:
0x226a2fa2556c48245e57cd1cba4c6c9e67077dd2
Before using any address, compare it against the official documentation.
Limitations: market data comes from one aggregator, CoinGecko, and moves constantly. Figures from 25 October 2026 had no exact timestamp on the page. Crypto assets are volatile and you can lose your capital; this is not investment advice.
